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Partial protein sequence of mouse and bovine kidney angiotensin
converting enzyme. Angiotensin converting enzyme (ACE) plays an
important role in the regulation of renal blood pressure by the hydrol-
ysis of the inactive precursor peptide angiotensin I to the potent
vasopressor angiotensin 11. Renal ACE is a surface membrane protein
of both endothelium and tubular epithelium. Enzymatically active ACE
was isolated from renal homogenates by chromatography using an
affinity column constructed by linking an ACE inhibitor, lisinopril, to
Affi-Gel 15. Analysis of eluates from this column showed that ACE
activity was increased greater than 500-fold. SDS-polyacrylamide gel
electrophoresis demonstrated a single band of molecular weight 144 kD
(mouse) and 149 kD (bovine). N-terminal amino acid sequence analysis
revealed:
1 10 20
Mouse LDPGLQPGNFSPDEAGAQLF
Bovine ELDPALQPGNFPADEAGAQI FA
10 20
Though bovine ACE has one additional N-terminal amino acid, these
two partial sequences are highly homologous (16 of 20 positions are
identical). Mouse ACE was digested with trypsin and the peptides were
isolated by reverse phase HPLC. Analysis of the amino acid sequences
showed that these tryptic peptides were unique to ACE. Thus, we were
able to isolate ACE from bovine and mouse kidneys and show that they
had substantial structural homology. They were also quite similar to
that from rabbit lung.
Angiotensin converting enzyme (ACE) (EC 3.4.15.1) is a
protease that catalyzes the hydrolysis of dipeptides from the
carboxyl terminus of polypeptides. In this way the enzyme
degrades bradykinin, a potent vasodilator, and converts angio-
tensin I (Ang I) to the potent vasoconstrictor, angiotensin II
(Ang II) [1—6]. Ang II markedly influences kidney hemodynam-
ics and thus ACE, by converting the non-vasoactive Ang Ito
Ang II plays an important role in the control of hemodynamics
within the kidney [71.
We are interested in studying the control of ACE expression
on kidney endothelial and epithelial cell surfaces, and as an
initial step towards that goal, report the isolation and partial
sequence of bovine kidney cortex and mouse kidney ACE.
Building on the work of Bull et al, Pantoliano et al, and Harris
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et al in the use of ACE inhibitors and other ACE substrate
analogues in constructing affinity columns [8—10], we used the
ACE inhibitor lisinopril linked to Affi-Gel 15 to isolate bovine
kidney cortex and mouse kidney ACE. These proteins were
found to have substantial N-terminal amino acid sequence
homology.
Methods
Lisinopril (N-[(5)- I -carboxy-3-phenylpropyl]-L-lysyl-L-pro-
line) used in this study was from Merck Sharp and Dohme
Research Laboratories (Rahway, New Jersey, USA). Affi-Gel
IS and acrylamide were purchased from BioRad Lab (Rich-
mond, California, USA). Proteins were analyzed using 8%
SDS-polyacrylamide gels as described by Laemmli [11]. Silver
staining of SDS-protein gels was performed by the method of
Wray et at [121. Protein concentration was measured using
albumin as standard by the method of Bradford with Commas-
sie Brilliant Blue G-250 dye concentrate purchased from
BioRad [13]. Diethylaminoethyl DE 52 cellulose was purchased
from Whatman. Other chemicals were purchased from Sigma
Chemical Company (St. Louis, Missouri, USA). All sequencer
reagents were from Applied Biosystems, Foster City, Califor-
nia, USA.
ACE activity was measured by the hydrolysis of hippuryl-
glycine-glycine (Boehringer-Mannheim #789011) as described
by Neels, van Sande and Scharpe [14]. Here one unit is the
amount of enzyme required to release I micromole of hippuric
acid per minute per titer. ACE was also occasionally measured
by the hydrolysis of 3H-benzoyl-phenylalanine-alanine-proline
(Ventrex) as described by Ryan et al [15].
One hundred milligrams (227 M) of lisinopril was dissolved
in 15 ml of reagent grade methanol. Twenty-two milliliter of
Affi-Gel 15 was warmed to 4°C and washed rapidly with cold
methanol. After draining, the gel was added to the lisinopril
solution and mixed by constant inversion at room temperature
overnight. Thirty-two microliters (229 M) of ethanolamine was
then added and mixed at room temperature for an additional 24
hours. This organic base was added to maintain the rate of
lisinopril-Affi-Gel 15 coupling by keeping the primary amine of
lisinopril in the non-protonated form. The reaction was stopped
by adding an excess of glycine to bind to unoccupied sites on
the agarose. No attempt was made to quantitate the coupling
efficiency of Iisinopril to Affi-Gel 15. The affinity resin was
extensively washed with methanol, then water, then a solution
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Table I. Purification of mouse kidney ACE M B
Specific
activity
Protein Enzyme units/mg Yield° Purification°
mg/in! units/mi protein Jid
Detergent extract 8.13 1,754 216 100
of kidney
DEAE cellulose 7.65 4,412 576 32 2.7
Affinity 0.51 149,114 292,380 IS 1354.7
chromatography
a ACE activity was measured as described by Neels, van Sande and
Sharpe [141. Units are expressed as micromoles of hippuric acid
generated per mm per liter. Protein concentration was measured by the
method of Bradford [13].
b Minimum yield values as portions of the detergent extract and the
DEAE cellulose eluate were not further purified.
Comparison of ACE activity to that of the starting detergent
extract.
of 20 mrvi MES (2-N-Morpholinoethanesulfonic Acid), pH 6.0,
0.5 M NaCI, 100 /.M zinc acetate and 0.1% Triton X-lOO and was
loaded onto a column I x 20 cm.
Seventy grams of kidney from adult male NIH Swiss mice
were crushed in liquid nitrogen. Subsequent manipulations until
affinity chromatography were carried out at 4°C. The powdered
kidneys were washed in 400 ml of 5 m'vi Tris, pH 7.75 and then
400 ml of 5 mivi Tris, pH 7.75 with 0.5% of the detergent Triton
X-100. This was stirred for one hour and then sonicated for
three minutes with a Sonifier sonicator set at 70% burst and 100
watts. After centrifugation for 15 minutes at 20,000 x g, the
liquid phase was dialyzed against 10 m potassium phosphate
buffer, pH 7.5 containing 0.025% Triton X-lOO (Buffer A)
overnight. Aliquots of the kidney extract were then loaded onto
2.5 >< 40 em DE-52 DEAE cellulose columns as described by
Gonhagen-Roska and Fyhrquist [161. The columns were
washed with several column volumes of Buffer A and eluted
with 0.2 M KCI in Buffer A. Those fraction', containing ACE
activity were pooled and dialyzed against 20 mrvi MES, pH 6.0,
0.5 M NaCI, 100 !LM zinc acetate, and 0.1% Triton X-lOO (Buffer
B). The kidney extract was warmed to room temperature anti
passed over the lisinopnil affinity column at a rate of approxi-
mately 40 mI/hour. The affinity column was washed with Buffer
B and then Buffer B without Triton X-lOO until the optical
density at 280 nanometers was less than 0.01. The column was
eluted with I ml aliquots of 50 m sodium borate, pH 8.9 as
described by Pantoliano, Holmquist and Riodan [9]. Those
aliquots with ACE activity were pooled and concentrated with
a Centricon 30 mieroconcentrator (Amicon, Lexington, Massa-
chusetts, USA). Bovine kidney was purchased frozen from
Pel-Freeze, thawed at 4°C, and the cortex removed. This tissue
served as the basis for developing the above protocol. We have
not investigated if the affinity column will isolate ACE without
a preliminary DEAE ion exchange step.
Purified mouse kidney ACE (265 rg) was denatured by
boiling for three minutes and digested for four hours at 37°C
with 3.0 zg of trypsin (Sigma T-8642) in 45 mist Tris. pH 8.0.
Half of this was loaded onto a Vydac C.4 HPLC column
mounted in a Beckman 344 H PLC. Elution of the column was
as follows: Solution A consisted of 0.12% trifluoroacetic acid in
water, Solution B consisted of 0.1% trifluoroacetic acid in
Fig. I. Purified mouse (M) and boi inc (B) ACL. Aliquots (I g) of
purified mouse and bovine kidney ACE sscre separated on an 8Y
SDS-polyacrylamide gel as described by [,aemmli [Ill. The gel was
fixed in 5O methanol containing 0.038 formaldehyde and silver
stained as described by Wray ci al [121. The size in kilodaltons as
determined by protein standards (Pharmacia) is indicated on the right.
acetonitrile. The column was eluted with a linear gradient of 0
to 60% Solution B over a one hour period, with O.D. measure-
ments at 225 nm. Peaks were collected manually, brought to
dryness, and resuspended in 30% acetic acid prior to amino acid
sequence analysis.
Amino terminal sequence determinations of the whole ACE
protein and tryptic peptides were performed using an Applied
Biosystems Model 470A gas-phase sequencer equipped with a
Model 120 A on-line PTH analyzer. To determine N-terminal
sequence of both bovine and mouse ACE, approximately 160
picomoles of protein were applied to the glass fiber filter
(previously treated with bioprene plus) and the sequence deter-
mined using the standard PTH program (Applied Biosystems).
Results
Table I presents the result of the isolation of mouse kidney
ACE. In this protocol the lisinopril affinity column resulted in a
single pass purification exceeding 500-fold. i'o assess the purity
and molecular weight of the recovered protein, 1 rg aliquots of
bovine and mouse ACE were denatured and analyzed on an
SDS-polyacrylamide gel (Fig. I). A single protein of molecular
weight 149 kDa from bovine kidney and 144 kDa from mouse
kidney was identified. These molecular weights are very similar
to the 139 to 140 kDa reported for rabbit lung ACE [4]. The
isolated proteins enzymatically degraded two ACE synthetic
substrates hippuryl-glycine-glycine and benzoyl-phenylalanine-
alanine-proline and were inhibited by I xM lisinopril and 1 mist
EDTA as has previously been described for ACE [17].
The amino acids in 16 of the 20 positions available for
comparison between mouse and bovine ACE were identical
(Fig. 2). In three of the four positions that differ, the hydropho-
bic nature of the side chains was conserved (glycine/alanine,
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I V
Mouse LDPGLQPGNFSPDEAGAQLF
Bovine E———A PA I —A
Rabbit T L——D—AA—N———R-—A
I I V
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Fig. 2. N-terminal amino acid sequence of mouse and bovine ACE.
TheN-terminal amino acid sequence of mouse and bovine kidney ACE
is compared to the published sequence of rabbit lung ACE 117]. The
mouse sequence contains one less N-terminal amino acid than that of
bovine or rabbit. Non-identical sequences are indicated. The one letter
amino acid code is: A, alanine; C, cysteine; D, aspartic acid; E,
glutamic acid; F, phenylalanine; 6, glycine; H, histidine; I, isoleucine;
K, lysine; L, leucine; M, methionine; N, asparagine; P, proline; Q,
glutamine; R, arginine; S, serine; T, threonine; V, valine; W,
tryptophan; Y, tyrosine.
proline/alanine, and leucine/isoleucine at mouse positions 4, 12,
and 19) [18]. At position 11, the polar residue serine in the
mouse was replaced with the nonpolar proline in bovine ACE.
A comparison of the sequence of rabbit ACE showed them to
be homologous though less conserved than a mouse-bovine
comparison (rabbit ACE is identical to bovine ACE at 13 of 21
positions and to mouse ACE at 14 of 20 positions). A computer
search of the Protein Identification Resource, National Biomed-
ical Research Foundation's protein sequence bank showed that
the sequences determined had no significant homologies with
other reported protein sequences.
The pattern of elution of the tryptic fragments of mouse ACE
are shown in Figure 3A. Figure 3B shows the partial amino acid
sequence determined from these peptides. Computer analysis
of the amino acid sequences of these fragments demonstrated
no consistent homologies with other protein sequences includ-
ing rabbit kidney neutral endopeptidase [191.
Discussion
We report the isolation of ACE from mouse and bovine
kidney. Eluates from an affinity column revealed single protein
bands with a molecular weight similar to that previously de-
scribed for ACE [41. These proteins enzymatically degraded
artificial ACE substrates and were inhibited by small amounts
of the ACE inhibitor lisinopril. EDTA was found to inhibit the
enzymatic action of these proteins as expected for ACE which
requires Zn+ + for activity [1, 4]. Finally the N-terminal amino
acid sequences reported here were highly homologous to that
previously reported for rabbit lung ACE and identical to that of
bovine kidney ACE published by St. Clair et a! [201. These data
establish that it is angiotensin converting enzyme that has been
isolated from bovine and mouse kidney.
The majority of kidney cortical tissue is composed of proxi-
mal tubules which have a large amount of ACE in their brush
border, and thus the majority of the ACE isolated and se-
quenced in this study must be of tubular epithelial origin.
Whether ACE produced by renal or pulmonary endothelium is
identical to that produced by tubular epithelium is not known.
However, studies of the immunogenicity, molecular weight and
kinetics suggest the ACE from the lung and kidney are indis-
tinguishable [2 1—24]. This contrasts to the ACE-like enzyme
B
Peak
A
B
C
D
E
F
G
Fig. 3. Tr,'ptic fragments of mouse kidney ACE. Mouse ACE (265
was digested with trypsin and loaded on a Vydac C4 reverse phase
HPLC column. The column was eluted over 60 mm with a linear 0 to
60% solution of 0.1% trifluoroacetic acid in acetonitrile. A. The eluted
pattern of tryptic fragments with letters A-G indicating fragments found
suitable for amino acid sequence analysis. B. The time of elution and
partial N-terminal amino acid sequence of these ACE fragments. The
one letter amino acid code is as described in Figure 2.
produced by the testis which differs in size, N- and C-terminal
amino acids and pattern of expression from ACE produced in
the kidney or lung [25—29]. The exact number of genes encoding
ACE and the complete sequence of this large protein awaits the
cloning and analysis of the ACE gene.
Though very little amino acid sequence data has been pub-
lished, many reports have previously detailed the isolation of
ACE from a variety of organs and animals. Recent studies have
used affinity chromatography to simplify ACE isolation proto-
cols [5]. Thus Pantoliano used the ACE inhibitor N-[1(S)-
carboxy-5-aminopentyl]-L-phenylalanyglycine immobilized to
Sepharose with a long spacer arm to isolate rabbit lung ACE [9].
Bull, Thornberry and Cordes used the ACE inhibitor lisinopril
bound to Sepharose to purify rabbit lung and human sera ACE
[8]. Lanzillo used the same protocol to isolate ACE from other
human tissues [24].
The protocol used in this study took advantage of the
previous studies but differed in several significant ways. A
commercially available matrix, Affi-Gel 15, was used to bind
lisinopril in constructing an affinity resin. Affi-Gel 15 contains a
A A B C D EF G
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large number of ligand binding sites and a long spacer arm. The
spacer arm is supplied derivatized with an active ester group so
that a ligand such as lisinopril, containing a primary amine and
soluble in methanol, can bind efficiently under nonaqueous
conditions. The lisinopril-Affi-Gel 15 affinity matrix bears a
positive charge at physiologic pH. This may aid in binding ACE
which as been reported to he an acidic protein with apI of 4.3
to 5.2 [5]. Finally some ligands have a marked change in affinity
for ACE over a small change in pH [91. The lisinopril affinity
matrix in this study behaves similarly to those described by
Pantoliano et a! in that a small change of pH (from 6.0 to 8.9)
resulted in elution of the enzyme from the affinity matrix [9]. As
the eluted enzyme was catalytically active, this method proved
to be much simpler than those requiring elution of the enzyme
by excess ligand followed by extensive dialysis as described by
others [8].
Angiotensin converting enzyme has been intensively studied
since it was first described by Skeggs et al [1, 2]. It has become
clear that this protease is produced in a regulated fashion by a
number of tissues including endothelium, renal tubular epithe-
hum, activated macrophages, testis, and brain [4, 5]. Here we
report the isolation of mouse ACE, an animal model that will
allow future study of the control of ACE gene expression to use
the many strains, the large amount of genetic data, and the
cultured glomerular endothelial cells available in this species
[30]. The information obtained from the tryptic digestion of
mouse kidney ACE provides the basis for future studies to
identify ACE cDNA.
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